What Makes a Brain Organoid a Valid Disease Model?

Brain organoids have become powerful tools for studying neurological disorders, offering researchers a three-dimensional model that more closely resembles human brain tissue than traditional two-dimensional cell cultures. But as their use in disease modeling continues to grow, one question remains essential: What makes a brain organoid a valid disease model?

A successful brain organoid model must accurately replicate key characteristics of the disease it is intended to study. Researchers often evaluate organoids by examining cellular composition, gene expression, tissue architecture, and developmental pathways. While these biological markers are important, they only tell part of the story.

To truly validate a brain organoid as a representative disease model, researchers must also determine whether it functions like the human tissue it is designed to mimic. This process, known as functional validation, measures how neurons communicate, form networks, and respond to external stimuli or therapeutic interventions.

Functional measurements are especially important in neurological diseases where altered neural activity is a defining feature. Disorders such as epilepsy, autism spectrum disorders, Tourette syndrome, Parkinson's disease, and Alzheimer's disease often involve changes in neuronal signaling long before structural abnormalities become apparent. Without measuring these functional changes, researchers may miss critical disease phenotypes.

Electrophysiology provides one of the most direct methods for assessing neural function. Unlike imaging techniques that infer activity through indirect signals, electrophysiological recordings capture real-time electrical communication between neurons, providing valuable insight into network behavior, synchronization, and neuronal firing patterns.

As disease modeling advances, many researchers are moving beyond surface-level measurements and seeking technologies that can evaluate neural activity throughout intact 3D organoids. Measuring activity from within the tissue provides a more comprehensive understanding of how neural circuits develop, interact, and respond to experimental treatments.

The SomaFocus™ platform was developed to address this need by enabling automated electrophysiological recordings from inside intact brain organoids. Rather than requiring slicing, plating, or extensive sample preparation, SomaFocus measures functional neural activity within the organoid's native three-dimensional environment, helping researchers generate more physiologically relevant data.

As organoid technology continues to shape neuroscience and drug discovery, combining structural, molecular, and functional data will be essential for building reliable neural models. Functional validation is no longer simply an added layer of analysis—it is becoming a key component of demonstrating that a brain organoid truly represents human disease.

Interested in learning more? Discover how SomaFocus helps researchers validate brain organoid models by measuring functional neural activity deep within intact organoids.